Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates
Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates
Novel 2-Substituted Quinoline Derivatives, And Method For Preparing Same
申请人:Fournet Alain
公开号:US20120225903A1
公开(公告)日:2012-09-06
The invention relates to 2-substituted quinoline derivatives, to a method for preparing same, and to the use thereof for drug production, particularly for treating infections caused by protozoa, such as leishmaniases, trypanosomiases, toxoplasmoses, and/or infections caused by retroviruses such as, for example, HIV or HTLV.
[EN] NOVEL 2-SUBSTITUTED QUINOLINE DERIVATIVES, AND METHOD FOR PREPARING SAME<br/>[FR] NOUVEAUX DERIVES DE QUINOLEINES 2-SUBSTITUEES ET UN PROCEDE POUR LEUR PREPARATION
申请人:INST RECH DEVELOPPEMENT IRD
公开号:WO2009150318A1
公开(公告)日:2009-12-17
Dérivés de quinoléines 2-substituées, un procédé pour leur préparation et leur utilisation pour la production de médicaments, notamment pour le traitement des infections dues à des protozoaires, telles que les leishmanioses, les trypanosomiases, les toxoplasmoses, et/ou les infections dues à des rétrovirus comme par exemple le VIH ou le HTLV.
Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates
A study comparing the chemical oxidation of drug candidates with cell-based metabolism (liver microsomes, hepatocytes) shows that biomimetic oxidation can replace the biological approach, thus allowing access to large quantities of metabolites, which can also be used for the preparation of new products.